NABL accreditation & ICMR approval for Metropolis Healthcare's lab dedicated for COVID-19 testing

The group now has three ICMR approved labs for testing in Maharashtra, with daily capacity of 4,000 tests

Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd
Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd


Metropolis Healthcare Ltd, one of India’s largest chain of pathology labs, today announced that it has built a dedicated COVID-19 testing laboratory in Thane, Maharashtra which is approved by Indian Council of Medical Research (ICMR) and accredited by the nodal accreditation body, National Accreditation Board for Testing and Calibration Laboratories (NABL). In addition to its lab in Mumbai and in Pune, this third dedicated facility in the state will now increase its testing capacity to conduct COVID-19 tests. The daily capacity of all these three labs put together stands at 4000.

Ameera Shah, Promoter and Managing Director, Metropolis Healthcare Ltd, said, “Covid-19 testing needs to increase exponentially and, to meet the needs of the state, we have added this laboratory with an enhanced capacity. Four of our labs across India are ICMR approved. Our only focus in such times is to support the local government and municipal authorities to increase the number of tests conducted each day in order to fight this pandemic.”

Metropolis Healthcare Ltd was one of the first laboratories to be approved by ICMR for COVID-19 testing and has been at the forefront since day one. Metropolis Healthcare Ltd, a CAP (College of American Pathologists) and NABL accredited lab has over 25 years of experience in conducting RNA-PCR assays.  It is one of the largest path lab chains in India with over forty years of experience in pathology. It is also conducting free testing for underprivileged, patients from low-income households and for essential service workers through various CSR initiatives.